Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Copper Faces Two-Year Shortage, Will Peak at Over $10,000, Trafigura Says
Copper supplies will lag demand for at least the next two years, with prices peaking over $10,000 a metric ton in the second quarter next year, according to Trafigura Beheer BV, which considers itself the world’s second- largest trader of industrial metals.
Copper will move from a balanced market this year to shortages of 800,000 tons in both 2011 and 2012 at current prices, Simon Collins, head of refined metals at Trafigura in Lucerne, Switzerland, said in an interview yesterday. That’s even before demand climbs as exchange-traded funds backed by the metal are introduced, he said.
Such funds “will result in higher prices, which in turn will affect price-sensitive demand and price-sensitive supply,” Collins said. “Consumers are concerned about an ETF. Inventories are already relatively low.”
Copper prices are up 21 percent this year, and reached a record $8,973.50 a ton today, partly as manufacturers and other buyers who anticipate shortages build inventories to meet demand for next year, Collins said. Imports into China, the world’s largest consumer, typically are strongest in the second quarter, helping to boost copper prices and leading gains in lead, nickel and aluminum, he said. Copper stockpiles tracked by the London Metal Exchange have slid 30 percent this year.
http://www.bloomberg.com/news/2010-12-07/copper-faces-2-year-shortage-peak-over-10-000-trafigura-says.html
If he can hit 15-20 stores a week, it will be much quicker than 6-12 months.
I'm almost inclined to have Liang stay in SE Asia for 4-6 months or however long it takes him to find funding. He seems to have the contacts and credibility to achieve that.
Very good point. Copper and Uranium will be on every investor's radar. This one has huge exposure to both.
Time for Eric to start walking the walk too, bud.
Yes, sounded like 2nd week of December it was to start.
Decent volume today.
Looks like breakout confirmed on the weekly...much more room to run.
Probably a couple more weeks on this Denovo. Frustrating for sure, but the DRTV continues in Canada and the UK.
Put a few drops of WC on the shovel,
might add some banana power and lubrication.
Whether we like it or not, we are tied to the hip with NAK. Let's deal with it.
It can be refitted with seats and
wait for it....
a pool table.
Doug should be coming home Wednesday. He will be very excited I'm sure.
Kind of reminds me of the powerlifters who use horse liniment on their pulled muscles. Horses, many times, are treated like royalty, since they are a huge investment.
There is absolute no reason not to average up in this case.
Something for you to consider to get views up to around 50k would be to hire someone to promote the videos to a targeted audience. Usually you can get 50k views for about 300 bucks.
Agreed on the whales, saw a 1.2 million bell buy on Tuesday. About 60k worth of stock.
0.0547 1222220 OBB 15:58:29
Hoping that the FDA clears their backlog by the first of the year.
Thank you for the intelligent response. Copper and Uranium will definitely be in focus for 2011. This one is way under radar at this point.
Talk to me belgian, what are you seeing?
1st page, 4th spot.
The keyword search 'removing spray paint from car', brings your video up on page 2. not sure how many will use the word enamel.
I am. Just hope this mrscupscup doesn't get a big head since he's now an internet celebrity ;)
nice! Your video, as well as a link to the corp. site come up page 1 on google on that keyword search.
Natural gas is a nice "bridge" for the next 20-30 years until a better alternative is found. Factories, trucking fleets, and buses can be converted to run on ng. The US will begin exporting liquid natural gas in the next 4-5 years, since we have so much.
Nuclear will be the energy of choice going forward, especially in China and India.
BIEL is in good company with those brand names.
Agreed. Communication with FDA is a good thing, moving in the right direction. In the meantime, we need 10-15k orders from the DRTV campaign in Canada and UK, cash flow is king.
Do you have a link?EDIT: found it
Thursday, December 09, 2010
Recent Updates – BioElectronics Corporation
BioElectronics has many investor updates to share, in addition to the press release that went out today about our product improvements. These updates include PR activity in UK, Allay UK TV test, Allay TV appearances, FDA clarification request, HealFast at Baltimore equine show, new Canadian ActiPatch commercial, Eastern European orders, and exciting case study results.
United Kingdom Public Relations Activity: We hired the services of Premier PR, a leading PR firm in the UK, to enhance and maximize our Allay campaign. Through the use of strong PR activities, we aim to establish retail sales in the UK, and gain better awareness of the product benefits and brand messages. To learn more about Premier PR, please visit www.premierpr.com.
Allay UK Television Test: After an initial, successful two week television test in the UK, we are excited to launch phase B of our TV test. In phase B, we are using a different commercial, targeting a younger demographic. The commercial will air by the end of the year on SKY satellite channels and E4 terrestrial channel. Both venues capture a very large audience. The new airing schedule will expose our commercial to 1.2m actual viewers in our target population.
Allay Television Appearances: We were happy to see Allay on “The Doctors” show last week. This TV exposure follows many other coverage items, where we continue to strengthen our brand. Allay is also scheduled to appear in Canada on the GlobalTV channel, in upcoming weeks. To see all our past TV items, including the item from “The Doctors,” please visit http://bielcorp.com/products/allay/allay-in-the-news/.
Allay DeNovo Application with the US-FDA: Earlier this week, BioElectronics received a letter from the US-FDA asking for clarifications about our Allay DeNovo application. A DeNovo application is submitted for devices that have no predicate and are of low-risk. The application requests the FDA to create a new classification and category, thus establishing a need for category controls. The FDA requested us to further define general controls for the new category and clarify previously presented clinical information. We are formulating our response, with help from several experts in the fields of bio-physics, medicine, FDA regulations and statistics.
HealFast Equine Show Appearance: BioElectronics’ HealFast was exhibited this week at the annual convention of the American Association of Equine Practitioners in Baltimore. eMarkets Group, LLC, the distributor of HealFast, introduced our new and improved shorter duration and lower cost product device into their product line and exhibited the new device at the convention.
New ActiPatch Canadian Commercial: We have a new edit for our back pain commercial currently running in Canada. Early results of the new commercial show an increase in our sales, but we need to obtain better repetitions and overall optimization to achieve our target numbers. To view our spot, please click HERE.
Eastern Europe Orders: Our Eastern European distributor Union Bionic, has made an initial order for new countries: Czech Republic, Poland, Ukraine and Hungary. We look forward to their successful campaigns and repeat orders.
Happy Story for the End: Our distributor in Netherlands started a new test for wound care in a leading Dutch medical institution. One of the test patients is a 105 year old woman who had bad diabetic ulcer on her leg. Within a week of using RecoveryRx, the black borders of her wound disappeared, and her wound was closing very fast, while the hyper-granulation diminished. These stories are the reason we are in this business – - we want to help many more patients experience the same results and change the way people heal.
http://bielcorp.com/investors/investor-updates/
Let's see if Fred can get 100 carts placed in the next 3 weeks. That's a worthy goal for him.
Copper and Uranium will lead the way in 2011. Without Uranium, the lights go out!
Not sure. That's a good question for Colorofmoney.
CEO bought in at .60, so little downside risk on this one.
MIMEDX GROUP INC (MDXG)
Petit Parker H CB 12/31/09 1,866,667 $ 0.60 1,882,222
Good stuff! Just a matter of time for this one.
Very strange. Hoping for a green close.
BIEL NEWS--BioElectronics Introduces Its New Disposable Device to the US Market
Now Drug-Free, Healing Pain Relief for Less Than the Cost of Common Drug Therapies
Press Release Source: BioElectronics Corporation On Thursday December 9, 2010, 9:00 am
FREDERICK, MD--(Marketwire - 12/09/10) - BioElectronics Corp. (Pinksheets:BIEL - News), the maker of inexpensive, disposable drug-free anti-inflammatory devices, today announced the introduction of its new, inexpensive and ultra-thin medical device to the US Market.
"Our new ultra-thin microchip provides clinically proven pain relief in a 7-day easy-to-wear medical device," said Arnon Horev, VP Sales and Marketing at BioElectronics Corporation. "The new model provides drug-free pain relief that is highly price competitive with pain medications or hot & cold therapies, with its only side effect being healing. This lighter, thinner and disposable new version is tailored to consumer needs, including treatment of menstrual pain, acute musculoskeletal pain and wound healing."
The new product is being presented by the Company's veterinary products distributor this week at the annual conference of the American Association of Equine Practitioners in Baltimore.
About BioElectronics Corporation
BioElectronics Corporation is the award winning medical device developer and manufacturer of advanced medical devices. Its products are ActiPatch® Therapy, for over-the-counter treatment of back pain and other musculoskeletal complaints, the Allay™ menstrual cycle pain therapy, and RecoveryRx for surgical procedures and wound care. The unique therapy delivery system, using patented technology, provides a cost-effective home care to reduce soft tissue pain and swelling. For more information, please see www.bielcorp.com.
BIEL NEWS--BioElectronics Introduces Its New Disposable Device to the US Market
Now Drug-Free, Healing Pain Relief for Less Than the Cost of Common Drug Therapies
Press Release Source: BioElectronics Corporation On Thursday December 9, 2010, 9:00 am
FREDERICK, MD--(Marketwire - 12/09/10) - BioElectronics Corp. (Pinksheets:BIEL - News), the maker of inexpensive, disposable drug-free anti-inflammatory devices, today announced the introduction of its new, inexpensive and ultra-thin medical device to the US Market.
"Our new ultra-thin microchip provides clinically proven pain relief in a 7-day easy-to-wear medical device," said Arnon Horev, VP Sales and Marketing at BioElectronics Corporation. "The new model provides drug-free pain relief that is highly price competitive with pain medications or hot & cold therapies, with its only side effect being healing. This lighter, thinner and disposable new version is tailored to consumer needs, including treatment of menstrual pain, acute musculoskeletal pain and wound healing."
The new product is being presented by the Company's veterinary products distributor this week at the annual conference of the American Association of Equine Practitioners in Baltimore.
About BioElectronics Corporation
BioElectronics Corporation is the award winning medical device developer and manufacturer of advanced medical devices. Its products are ActiPatch® Therapy, for over-the-counter treatment of back pain and other musculoskeletal complaints, the Allay™ menstrual cycle pain therapy, and RecoveryRx for surgical procedures and wound care. The unique therapy delivery system, using patented technology, provides a cost-effective home care to reduce soft tissue pain and swelling. For more information, please see www.bielcorp.com.